Performance overview
Value at beginning of month: $115,325.33
Value at end of month: $120,535.66
Month over month change: +4.51%
Total CAGR: 25.34%
Related indices, monthly change
NASDAQ: +3.16%
IVV (iShares Core S&P 500): +2.56%
IBB (iShares NASDAQ Biotechnology Index): -5.24%
MXI (iShares Global Materials): +3.24%
VEGI (iShares MSCI Global Agriculture Producers): +2.28%
ICLN (iShares Clean Energy): +3.67%
Individual performances
The index again reached record highs. Its gains came from Genscript and Novozymes, who make up around 50% of the index and both were up modestly in October. Intrexon and Calyxt, the next largest members of the index led losses, which tempered the gains of the index during the month.
Changes made to index
None, you can view the index here.
Allocation as of October 27, 2017
